103 related articles for article (PubMed ID: 10102393)
21. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.
Yamaoka M; Yamamoto T; Ikeyama S; Sudo K; Fujita T
Cancer Res; 1993 Nov; 53(21):5233-6. PubMed ID: 7693335
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
23. A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer.
Bhargava P; Marshall JL; Rizvi N; Dahut W; Yoe J; Figuera M; Phipps K; Ong VS; Kato A; Hawkins MJ
Clin Cancer Res; 1999 Aug; 5(8):1989-95. PubMed ID: 10473076
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of angiogenesis of xenotransplanted squamous epithelial carcinomas. Effectiveness of TNP-470 in the nude mouse tumor model].
Eckardt A; Küttner C; Fokas K; Berens A
Mund Kiefer Gesichtschir; 2000 Sep; 4(5):315-9. PubMed ID: 11092185
[TBL] [Abstract][Full Text] [Related]
25. [Cancer therapy targeting tumor-induced neovascularization].
Sato K; Kato T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):295-300. PubMed ID: 7509149
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic inhibition for the treatment of head and neck cancer.
Gleich LL; Zimmerman N; Wang YO; Gluckman JL
Anticancer Res; 1998; 18(4A):2607-9. PubMed ID: 9703916
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of tumor growth and microvascular angiogenesis by the potent angiogenesis inhibitor, TNP-470, in rats.
Niwano M; Arii S; Mori A; Ishigami S; Harada T; Mise M; Furutani M; Fujioka M; Imamura M
Surg Today; 1998; 28(9):915-22. PubMed ID: 9744400
[TBL] [Abstract][Full Text] [Related]
28. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
Murata R; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
[TBL] [Abstract][Full Text] [Related]
29. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis.
Brem H; Gresser I; Grosfeld J; Folkman J
J Pediatr Surg; 1993 Oct; 28(10):1253-7. PubMed ID: 7505321
[TBL] [Abstract][Full Text] [Related]
30. Suppression of growth of Bomirski Ab melanoma and its metastasis in hamsters by angiogenesis inhibitor TNP-470.
Myśliwski A; Szmit E; Szatkowski D; Sosnowska D
Anticancer Res; 1998; 18(1A):441-3. PubMed ID: 9568116
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effect of TNP-470 on spontaneous liver metastasis of colon tumors in the rabbit.
Sano J; Sugiyama Y; Kunieda K; Sano B; Saji S
Surg Today; 2000; 30(12):1100-6. PubMed ID: 11193742
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Teicher BA; Holden SA; Dupuis NP; Kakeji Y; Ikebe M; Emi Y; Goff D
Breast Cancer Res Treat; 1995; 36(2):227-36. PubMed ID: 8534870
[TBL] [Abstract][Full Text] [Related]
33. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470).
Yamamoto T; Sudo K; Fujita T
Anticancer Res; 1994; 14(1A):1-3. PubMed ID: 7513139
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential.
Konno H; Tanaka T; Kanai T; Maruyama K; Nakamura S; Baba S
Cancer; 1996 Apr; 77(8 Suppl):1736-40. PubMed ID: 8608571
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line.
Miki T; Nonomura N; Nozawa M; Harada Y; Nishimura K; Kojima Y; Takahara S; Okuyama A
J Urol; 1998 Jul; 160(1):210-3. PubMed ID: 9628652
[TBL] [Abstract][Full Text] [Related]
36. [Therapy of carcinomatous peritonitis by the angiogenesis inhibitor TNP-470 in mice: analysis of timing and doses for intraperitoneal administration].
Tsujimoto H; Osaki K; Ohyama T; Sakakibara T; Ohgaki M; Imanishi T; Yamasaki J; Shirasu M; Shimotsuma M; Hagiwara A
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1527-30. PubMed ID: 7574750
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
Futami H; Iseki H; Egawa S; Koyama K; Yamaguchi K
Invasion Metastasis; 1996; 16(2):73-82. PubMed ID: 9030242
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Kudelka AP; Levy T; Verschraegen CF; Edwards CL; Piamsomboon S; Termrungruanglert W; Freedman RS; Kaplan AL; Kieback DG; Meyers CA; Jaeckle KA; Loyer E; Steger M; Mante R; Mavligit G; Killian A; Tang RA; Gutterman JU; Kavanagh JJ
Clin Cancer Res; 1997 Sep; 3(9):1501-5. PubMed ID: 9815836
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden.
Katzenstein HM; Rademaker AW; Senger C; Salwen HR; Nguyen NN; Thorner PS; Litsas L; Cohn SL
Clin Cancer Res; 1999 Dec; 5(12):4273-8. PubMed ID: 10632370
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effect of angiogenesis inhibitor TNP-470 on the human nasopharyngeal carcinoma cell line NPC/HK1.
Qian CN; Min HQ; Lin HL; Feng GK; Ye YL; Wang LG; Kuang ZJ
Oncology; 1999 Jul; 57(1):36-41. PubMed ID: 10394123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
